A cautionary tale - EU merger control rules may apply to pharma pipeline products

A cautionary tale - EU merger control rules may apply to pharma pipeline products

25.10.2016 EU law

In Case M.7872 – Novartis/GlaxoSmithKline (ofatumumab autoimmune indications), the European Commission claimed jurisdiction under the merger control rules over a transaction by virtue of which a yet to be fully developed biological drug was transferred to a purchaser. In applying the relevant jurisdictional test, the Commission made a series of observations which have far-reaching implications. 

This article has been published in Competition Law Insight,  20 September 2016. 

Read the article


Related news

14.03.2018 EU law
The Court of Justice of the European Union Rules that Intra-EU Investment Arbitration is Incompatible with EU Law: Reflections and Consequences for the Energy Charter Treaty

Articles - On the 6th of March 2018, the Court of Justice of the European Union (CJEU) held in a case between the Slovak Republic and Achmea (Case C-284/16, ECLI:EU:C:2018:158) that investment arbitration on the basis of the Netherlands-Slovakia Bilateral Investment Treaty (BIT) is incompatible with EU law, in particular Arts. 267 and 344 of the Treaty on the Functioning of the European Union (TFEU). 

Read more

16.02.2018 EU law
Who is a consumer? The dynamic approach to the concept of 'consumer' under the Brussels I Regulation

Short Reads - On 25 January 2018, the European Court of Justice ("ECJ") rendered a preliminary ruling in a case between Austrian citizen Maximilian Schrems and online social network Facebook. The ruling is important for two reasons. First, the ECJ approved a dynamic approach to the concept of 'consumer' under the Brussels I Regulation. Secondly, the ECJ clarified that the special consumer forum can only be invoked by the specific consumer who is party to the contractual relationship with the professional trader.

Read more

01.03.2018 EU law
ACM publishes key priorities for 2018 and 2019

Short Reads - On 13 February 2018, the Dutch Authority for Consumers and Markets (ACM) highlighted the key priorities it will pursue in 2018 and 2019. It will focus on the digital economy, making the energy market greener, prices of prescription drugs and competition in the port sector. Interested parties were invited to share their comments on the priorities and multiple statements online.

Read more

Our website uses cookies: third party analytics cookies to best adapt our website to your needs & cookies to enable social media functionalities. For more information on the use of cookies, please check our Privacy and Cookie Policy. Please note that you can change your cookie opt-ins at any time via your browser settings.

Privacy – en cookieverklaring